Characterisation of signalling by the Endogenous GPER1 (GPR30) Receptor in an Embryonic Mouse Hippocampal Cell Line (mHippoE-18)

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Evans, Nicholas J ^a   Bayliss, Asha L ^a   Reale, Vincenzina ^a   Evans, Peter D ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; ALDOSTERONE; CYCLIC AMP; DIARYLPROPIONITRILE; ESTRADIOL; FORSKOLIN; FULVESTRANT; G PROTEIN COUPLED RECEPTOR 30; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TAMOXIFEN; 1,3,5-TRIS(4-HYDROXYPHENYL)-4-PROPYL-1H-PYRAZOLE; 2,3-BIS(4-HYDROXYPHENYL)-PROPIONITRILE; ADENYLATE CYCLASE; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GPR30 PROTEIN, MOUSE; NITRILE; PHENOL DERIVATIVE; PYRAZOLE DERIVATIVE;

ARTICLE; CONCENTRATION RESPONSE; ENZYME ACTIVATION; HIPPOCAMPUS; IMMORTALIZED CELL LINE; MHIPPOE 18 CELL LINE; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CYTOLOGY; DRUG EFFECTS; MAMMALIAN EMBRYO; METABOLISM; MOUSE;

ADENYLYL CYCLASES; ALDOSTERONE; ANIMALS; CELL LINE; COLFORSIN; CYCLIC AMP; EMBRYO, MAMMALIAN; ESTRADIOL; HIPPOCAMPUS; MAP KINASE SIGNALING SYSTEM; MICE; NITRILES; PHENOLS; PYRAZOLES; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TAMOXIFEN;

EID: 84962086919     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152138     Document Type: Article

References (58)

1. Prossnitz ER, Arterburn JB. International Union of Basic and Clinical Pharmacology. XCVII. G protein-coupled estrogen receptor and its pharmacological modulators. Pharmacol Revs. 2015; 67: 505-540.
2. Srivastava DP, Evans PD. GPER 1-trials and tribulations of a membrane oestrogen receptor. J Neuroendocrinology. 2013; 25: 1219-1230.
3. Barton M, Meyer MR. Nicolaus Copernicus and the rapid vascular responses to aldosterone. Trends Endocrinology and metabolism. 2015; 26: 396-398.
4. Filardo EJ, Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab. 2005; 16: 362-367. PMID: 16125968
5. Filardo EJ, Thomas P. G-protein-coupled estrogen receptor-1 GPER-1: Its mechanism of action and role infemale reproductive cancer, renal and vascular physiology. Endocrinology. 2012; 153: 2952-2962.
6. Revankar CM, Cimino DF, Sklar IA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005; 307: 1625-1630. PMID: 15705806
7. Cheng SB, Quinn JA, Graeber CT, Filardo EJ. Down-modulation of the G protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway. J Biol Chem. 2011; 286: 22441-22455. doi: 10.1074/jbc.M111.224071 PMID: 21540189
8. Akama KT, Thompson LI, Milner TA, McEwen BS. Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled receptor30 (GPR30), an estrogen receptor that can be identified in hippocampal dendritic spines. J Biol Chem. 2013; 288: 6438-6450. doi: 10.1074/jbc.M112.412478 PMID: 23300088
9. Waters EM, Thompson LI, Patel P, Gonzales AD, Ye HZ, Filardo EJ, et al. G-protein-coupled estrogen receptor 1 is anatomically positioned to modulate synaptic plasticity in the mouse hippocampus. J Neurosci. 2015; 35: 2384-97. doi: 10.1523/JNEUROSCI.1298-14.2015 PMID: 25673833
10. Broselid S, Berg KA, Chavera TA, Kahn R, Clarke WP, Olde B, et al. G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs)and protein kinase A-anchoring protein 5 (AKAP5) that constitutively inhibits cAMP production. J Biol Chem. 2014; 289: 22117-27. doi: 10.1074/jbc.M114.566893 PMID: 24962572
11. Srivastava DP, Woolfrey KM, Evans PD. Mechanisms underlying the interactions between rapid estrogenic and BDNF control of synaptic connectivity. Neuroscience. 2013; 239: 17-33. doi: 10.1016/j.neuroscience.2012.12.004 PMID: 23246844
12. Sellers K, Raval P, Srivastava DP. Molecular signature of rapid estrogen regulation of synaptic connectivity. Frontiers in Neuroendocrinology. 2015; 36C: 72-89. doi: 10.1016/j.yfrne.2014.08.001
13. Kelly MJ, Rønnekleiv OK. Neural signaling of estradiol in the hypothalamus. Mol Endocrinol. 2015; 19: 645-657.
14. Toran-Allerand CD. Minireview: a plethora of estrogen receptors in the brain: where will it end? Endocrinology. 2004; 145: 1069-1074. PMID: 14670986
15. Matsuda K, Sakamoto H, Mori H, Hosokawa K, Kawamura K, Itose M, et al. Expression and intracellular distribution of the G protein-coupled receptor 30 in rat hippocampal formation. Neuroscience Letters. 2008; 441: 94-99. doi: 10.1016/j.neulet.2008.05.108 PMID: 18586395
16. Hammond R, Nelson D, Gibbs RB. GPR30 co-localizes with cholinergic neurons in the basal forebrain and enhances potassium-stimulated acetylcholine release in the hippocampus. Psychoneuroendocrinology. 2011; 36: 182-192. doi: 10.1016/j.psyneuen.2010.07.007 PMID: 20696528
17. Sanden C, Broselid S, Cornmark L, Andersson K, Daszkiewicz-Nilsson J, Martensson UE, et al. G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments. Mol Pharmacol. 2011; 79: 400-410. doi: 10.1124/mol.110.069500 PMID: 21149639
18. Funakoshi T, Yanai A, Shinoda K, Kawano MM, Mizukami Y (2006) G protein coupled receptor30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun. 2006; 346: 904-910. PMID: 16780796
19. Gingerich S, Kim GL, Chalmers JA, Koletar MM, Wang X, Wang Y, et al. Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models. Neuroscience. 2010; 170: 54-66. doi: 10.1016/j.neuroscience.2010.06.076 PMID: 20619320
20. Burman C, Reale V, Srivastava DP Evans PD. Identification and characterization of a novel Amphioxus dopamine D1-like receptor. J Neurochem. 2009; 111: 26-36. doi: 10.1111/j.1471-4159.2009.06295.x PMID: 19645747
21. Burman C, Evans PD. Amphioxus expresses both vertebrate-type and invertebrate-type dopamine D1 receptors. Invert Neurosci. 2010; 10: 93-105 doi: 10.1007/s10158-010-0111-0 PMID: 21113730
22. Srivastava D, Yu E, Kennedy K, Chatwin H, Reale V, Hamon M, et al. Rapid, non-genomic responses to ecdysteroids and catecholamines mediated by a novel Drosophila G-protein coupled receptor. J Neurosci. 2005; 25: 6145-6155. PMID: 15987944
23. Bayliss A, Roselli G, Evans PD. A comparison of the signalling properties of two tyramine receptors from Drosophila. J Neurochem. 2013; 125: 37-48. doi: 10.1111/jnc.12158 PMID: 23356740
24. Munirathinam G, Yoburn B. A simple procedure for assaying cAMP. Pharmacol Biochem Behaviour. 1994; 48: 813-816.
25. Insel P, Ostrom R. Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell Mol Neurobiol. 2003; 23: 305-314. PMID: 12825829
26. Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene. 1999; 18: 3085-3097. PMID: 10340380
27. Swatton JE, Sellers LA, Faull RLM, Holland A, Iritani S, Bahn S. Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain. Eur J Neurosci. 2004; 19: 2711-2719. PMID: 15147305
28. Bayliss A, Evans PD. Characterisation of AmphiAmR11 an amphioxus (Branchiostomafloridae) D2-dopamine-like G protein-coupled receptor. PLOSONE. 2013; 8(11): e80833. doi: 10.1371/journal.pone.0080833 PMID: 24265838
29. Gros R, Ding Q, Sklar LA, Prossnitz EE, Arterburn JB, Chorazyczewski J, et al. GPR30 expression is required for the mineralocorticoid receptor independent rapid vascular effects of aldosterone. Hypertension. 2011; 57: 442-451. doi: 10.1161/HYPERTENSIONAHA.110.161653 PMID: 21242460
30. Gros R, Ding Q, Liu B, Chorazyczewski J, Feldman RD. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am J Physiol Cell Physiol. 2013; 304: C532-C540. doi: 10.1152/ajpcell.00203.2012 PMID: 23283935
31. Ashton AW, Le TY, Gomez-Sanchez CE, Morel-Kopp MC, McWhinney B, Hudson A, et al. Role of Non-genomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury. Mol Endocrinol. 2015; 29: 1144-55. doi: 10.1210/ME.2014-1410 PMID: 26121234
32. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, et al. In vivo effects of a GPR30 antagonist. Nat Chem Biol. 2009; 5: 421-427. doi: 10.1038/nchembio.168 PMID: 19430488
33. Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG, et al. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J Steroid Biochem Mol Biol. 2011; 127: 358-366. doi: 10.1016/j.jsbmb.2011.07.002 PMID: 21782022
34. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, et al. Virtual and bio-molecular screening converge on a selective agonist for GPR30. Nat Chem Biol. 2006; 2: 207-212. PMID: 16520733
35. Peyton C, Thomas P. Involvement of epidermal growth factor receptor signalling in estrogen inhibition of oocyte maturation mediated through the G protein-coupled estrogen receptor (Gper) in Zebrafish (Danio rerio). Biol Reproduction. 2011; 85: 42-50.
36. Filardo EJ, Quinn JA, Raymond Frackelton A, Bland KI. Estrogen action via the G-protein-coupled receptor, GPR30: Stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002; 16: 70-84. PMID: 11773440
37. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005; 146: 624-632. PMID: 15539556
38. Pang YF, Dong J, Thomas P. Estrogen signaling characteristics of Atlantic craokerGPR30 and evidence it is involved in maintenance of oocyte meiotic arrest. Endocrinology. 2008; 149: 3410-3426. doi: 10.1210/en.2007-1663 PMID: 18420744
39. Lindsey SH, Liu L, Chappell MC. Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling. Steroids. 2014; 81: 99-102. doi: 10.1016/j.steroids.2013.10.017 PMID: 24246735
40. Lebesgue D, Traub M, De Butte-Smith M, Chen C, Zukin RS, Kelly MJ, et al. Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats. PLoS ONE. 2010; 5: e8642. doi: 10.1371/journal.pone.0008642 PMID: 20062809
41. Ruiz-Palmero I, Hernando M, Garcia-Segura LM, Arevalo M-A. G protein-coupled estrogen receptor is required for the neuritogenic mechanism of 17β-estradiol in developing hippocampal neurons. Mol Cell Endocrinol. 2013; 372: 105-115. doi: 10.1016/j.mce.2013.03.018 PMID: 23545157
42. Noel SD, Keen KL, Baumann DI, Filardo EJ, Terasawa E. Involvement of G protein-coupled receptor 30 (GPR30) in rapid action of estrogen in primate LHRH neurons. Mol Endocrinol. 2009; 23: 349-359. doi: 10.1210/me.2008-0299 PMID: 19131510
43. Lebesgue D, Reyna-Neyra A, Huang X, Etgen AM. GPR30 differentially regulates short latency responses of luteinising hormone and prolactin secretion to oestradiol. J Neuroendocrinol. 2009; 21: 743-752. doi: 10.1111/j.1365-2826.2009.01893.x PMID: 19523168
44. Woolley CS, McEwan BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci. 1994; 14: 7680-7687. PMID: 7996203
45. Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature. 1977; 390: 88-91.
46. Fraser CM, Arakawa S, McCombie WR, Venter JC. Cloning, sequence analysis, and permanent expression of a human a2-adrenergic receptor in Chinese hamster ovary cells. J Biol Chem. 1989; 264: 11754-11761. PMID: 2568356
47. Eason MG, Kurose H, Holt BD, Raymond JR, Liggett SB. Simultaneous coupling of α2-adrenergic receptors to two G-proteins with opposing effects. J. Biol. Chem. 1992; 267: 15795-15801. PMID: 1322406
48. Airriess CN, Rudling JE, Midgley JM, Evans PD. Selective inhibition of adenylyl cyclase by octopamine via a human cloned α2A-adrenoceptor. Brit J Pharmacol. 1997; 122: 191-198.
49. Micevych PE, Kelly MJ. Membrane estrogen receptor regulation of hypothalamic function. Neuroendocrinology. 2012; 96: 103-110. doi: 10.1159/000338400 PMID: 22538318
50. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, et al. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci. 2002; 22: 8391-8401. PMID: 12351713
51. Kenakin T. New concepts in pharmacological efficacy at 7-TM receptors: IUPHAR Review 2. Brit J Pharmacol. 2013; 168: 554-575.
52. Violin JD, Crombe AL, Soergel DG, Lark MW. Biased ligands at G-protein-coupled receptors: promise and progress. Trends Pharmacol Sci. 2014; 35: 308-316. doi: 10.1016/j.tips.2014.04.007 PMID: 24878326
53. Evans PD, Robb S, Cheek TR, Reale V, Hannan FL, Swales LS, et al. Agonist-specific coupling of G-protein coupled receptors to second messenger systems. Current neurochemical and pharmacological aspects of biogenic amines: their function, oxidative deamination and inhibition, edited by Yu P.M., Tipton K.F., Boulton A.A. Prog in Brain Res. 1995; 106: 259-268. Amsterdam: Elsevier Science BV.
54. Kenakin T. Agonist-receptor efficacy II: agonist-trafficking of receptor signals. Trends Pharmacol Sci. 1995; 16: 232-238. PMID: 7667897
55. Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, et al. β-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. PNAS. 2003; 100: 11406-11411. PMID: 13679574
56. Wisler JW, DeWire SM, Whalen EJ, Violin JD, Drake MT, Ahn S, et al. A unique mechanism of β-blockeraction: Carvedilol stimulates β-arrestin signaling. PNAS. 2007; 104: 16657-16662. PMID: 17925438
57. Evans PD, Bayliss A, Reale V. GPCR-mediated rapid, non-genomic actions of steroids: Comparisons between DmDopEcRand GPER1 (GPR30). General and Comparative Endocrinology. 2014; 195: 157-163. doi: 10.1016/j.ygcen.2013.10.015 PMID: 24188886
58. Cheng S-B, Dong J, Pang Y, LaRocca J, Hixon M, Thomas P. Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone. Mol Cell Endocrinology. 2013; 382: 950-959.